Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Download original image
Fig. 2. Expression levels of EMP2 across various cancer types. Significant differences determined by the Mann–Whitney U test are marked in black color (*p<0.05, **p<0.01, and ***p<0.001). The analysis was performed using the TNM plotter (https://tnmplot.com/) (Bartha and Gyorffy, 2021). ALL, Acute lymphoblastic leukemia; Adrenal, Adrenocortical carcinoma; AML, Acute myeloid leukemia; Breast, Breast invasive carcinoma; Colon. Colon adenocarcinoma; CNS, Central nervous system tumor; Esoph, Esophageal carcinoma; HNSCC, Head and neck squamous cell carcinoma; Kidney_ch, Kidney chromophobe cancer; Kidney_cc, Kidney renal clear cell carcinoma; Kidney_PR, Kidney renal papillary cell carcinoma; Liver, Liver hepatocellular carcinoma; LUAD, Lung adenocarcinoma; LUSC, Lung squamous cell carcinoma; NB, Neuroblastoma; Osteo, Osteosarcoma; PDAC, Pancreatic adenocarcinoma; Rectum, Rectum adenocarcinoma; Skin, Skin cutaneous melanoma; Stomach, Stomach adenocarcinoma; Testicular, Testicular germ cell tumors; Thyroid, Thyroid carcinoma; UCS, Uterine carcinosarcoma; UCEC, Uterine corpus endometrial carcinoma.
Biomolecules & Therapeutics 2024;32:697~707 https://doi.org/10.4062/biomolther.2024.168
© Biomolecules & Therapeutics